公开(公告)号：WO2012071535A3

公开(公告)日：2012-05-31

申请号：PCT/US2011/062085

申请日：2011-11-23

Applicant: AMGEN INC ,  BI, Mingda ,  ALVAREZ-NUNEZ, Fernando ,  ALVAREZ, Francisco Javier

Inventor： BI, Mingda ,  ALVAREZ-NUNEZ, Fernando ,  ALVAREZ, Francisco Javier

IPC: A61K9/14 ,  A61K9/00 ,  A61P5/18

Abstract: The present invention is directed to pediatric formulation of ( R )- N -[-1-(1-naphthyl)-ethyl]-3-[3-(trifluoromethyl)phenyl]propan-1-amine hydrochloride (hereinafter referred to as Cinacalcet HC1) and method of administering the same.

公开(公告)号：WO2012071535A2

公开(公告)日：2012-05-31

申请号：PCT/US2011062085

申请日：2011-11-23

Applicant: AMGEN INC ,  BI MINGDA ,  ALVAREZ-NUNEZ FERNANDO ,  ALVAREZ FRANCISCO JAVIER

Inventor： BI MINGDA ,  ALVAREZ-NUNEZ FERNANDO ,  ALVAREZ FRANCISCO JAVIER

IPC: A61K9/14 ,  A61K9/00 ,  A61P5/18

CPC classification number: A61K9/14 ,  A61K9/0095 ,  A61K9/143 ,  A61K9/146 ,  A61K31/137 ,  A61K47/02 ,  A61K2300/00

Abstract: The present invention is directed to pediatric formulation of (R)-N-[-1-(1-naphthyl)-ethyl]-3-[3-(trifluoromethyl)phenyl]propan-1-amine hydrochloride (hereinafter referred to as Cinacalcet HC1) and method of administering the same.

Abstract translation: 本发明涉及（R）-N - [1-（1-萘基） - 乙基] -3- [3-（三氟甲基）苯基]丙-1-胺盐酸盐（以下称为西那卡塞 HC1）及其施用方法。